Axogen Enters Into Definitive Agreement To Acquire BioCircuit Technologies

Sept. 10 (Reuters) - AxoGen, Inc. AXGN.O:

• Axogen enters into definitive agreement to acquire BioCircuit Technologies
• Axogen to buy BioCircuit for $200 million in cash
• Axogen said the deal is expected to be accretive to revenue, adjusted EBITDA margin and adjusted EPS in the first year
• Axogen said it will fund the purchase price with net proceeds from a public offering

Source text: ID:nGNX71R0QD

Further company coverage: AXGN.O